What Is BPC-157? Mechanism & Research Overview
Supplied strictly for in vitro laboratory research. Not for human consumption.
BPC-157 (Body Protection Compound-157) is a synthetic peptide that has become one of the most-discussed compounds in tissue-repair research. It is a fragment of a protein found in gastric juice, and much of the laboratory interest in it comes from its unusual chemical stability. Importantly, the research on BPC-157 is almost entirely preclinical — this guide summarises what it is and what animal and laboratory studies have examined, for research context only.
What is BPC-157?
BPC-157 is a synthetic pentadecapeptide — a chain of 15 amino acids — corresponding to a partial sequence of “body protection compound” (BPC), a protein isolated from gastric juice. It is often called a “stable gastric pentadecapeptide” because, unlike most peptides, it resists breakdown in the acidic environment of the stomach. That stability is part of what makes it of interest to researchers studying peptide behaviour and delivery.
Mechanism studied in preclinical models
In preclinical models, BPC-157 has been examined across several overlapping mechanisms:
- Angiogenesis — the formation of new blood vessels, which research links to the VEGFR2 receptor and the nitric oxide (Akt–eNOS) pathway.
- Collagen and fibroblast activity — effects on collagen synthesis and on the growth and migration of fibroblasts, associated with FAK–paxillin signalling.
- Growth hormone receptor — upregulation of growth hormone receptor expression in tendon fibroblasts in laboratory studies.
- Inflammatory modulation — reductions in inflammatory cytokine activity reported in animal models.
The state of the evidence
This is the most important section to read in context. A 2025 systematic review identified 544 BPC-157 articles published between 1993 and 2024; of the studies meeting inclusion criteria, the overwhelming majority were preclinical animal studies, with only a single clinical study. In animal models, BPC-157 has been investigated for effects on muscle, tendon, ligament, bone, and gastrointestinal tissue.
Reviewers consistently note that well-designed human trials are still lacking. BPC-157 is not an approved medicine in any jurisdiction, and no human efficacy has been established. It is appropriately treated as an investigational research compound only.
Stability and handling
BPC-157 is typically supplied as a lyophilised (freeze-dried) powder and stored frozen. It is noted in the literature for remaining stable in low-pH conditions where many peptides degrade rapidly — a property that has made it a frequent subject of laboratory stability and delivery research.
Often studied alongside TB-500
In musculoskeletal research literature, BPC-157 is frequently discussed alongside TB-500, a synthetic fragment of thymosin beta-4, as the two are commonly examined together in the context of tissue-repair research.
Research and sourcing considerations
As with any research peptide, reproducible results depend on verified identity and purity. Research-grade BPC-157 should be supplied with independent HPLC purity testing (≥99% purity) and a batch-specific certificate of analysis (COA) for the specific vial supplied.
DXB Peptides supplies research-grade BPC-157 for in vitro laboratory use — HPLC-tested to ≥99% purity with a batch-specific COA, cold-chain handled and delivered across the UAE.
Frequently asked questions
What is BPC-157? A synthetic pentadecapeptide derived from a protein found in gastric juice, studied in preclinical research for tissue-repair-related mechanisms such as angiogenesis.
Is BPC-157 approved? No. It is not an approved medicine in any jurisdiction, and its research base is almost entirely preclinical.
What has BPC-157 been studied for? In animal models, effects on angiogenesis and on muscle, tendon, ligament, bone, and gastrointestinal tissue. Human trials are lacking.
What purity should research-grade BPC-157 be? Look for independent HPLC testing at ≥99% purity, accompanied by a batch-specific certificate of analysis.
Important note
BPC-157 is supplied strictly for in vitro laboratory research. It is not a medicine, is not approved for human use in any jurisdiction, and is not for human consumption or in vivo administration.
Explore the full catalogue: Research peptides UAE